As of 2025-09-17, the Relative Valuation of Inozyme Pharma Inc (INZY) is (14.26) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.00 USD, the upside of Inozyme Pharma Inc based on Relative Valuation is -456.4%.
The range of the Relative Valuation is (11.24) - (18.81) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 11.4x | 7.9x |
| Forward P/E multiples | 6.8x - 11.9x | 9.4x |
| Fair Price | (11.24) - (18.81) | (14.26) |
| Upside | -381.0% - -570.3% | -456.4% |
| Date | P/E |
| 2025-06-30 | -2.42 |
| 2025-06-27 | -2.41 |
| 2025-06-26 | -2.42 |
| 2025-06-25 | -2.41 |
| 2025-06-24 | -2.41 |
| 2025-06-23 | -2.41 |
| 2025-06-20 | -2.41 |
| 2025-06-18 | -2.41 |
| 2025-06-17 | -2.41 |
| 2025-06-16 | -2.40 |